VIDEO: Clinical trials show efficacy of Vevye for dry eye disease

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Alice T. Epitropoulos, MD, FACS, discusses Vevye, a cyclosporine solution that treats signs and symptoms of dry eye disease.
Epitropoulos said Vevye (Harrow) is “the most potent cyclosporine commercially available at 0.1%,” but it is tolerable, comfortable and efficacious, adding that it has been shown to remain in the tears for up to 8 hours.
“Of the 1,100 subjects involved in the FDA clinical trials, 57% demonstrated an improvement in total corneal fluorescein staining at day 15, and 66% (Read more...)

Full Story →